Novo Nordisk Stock Sinks—But Is a Bottom Finally In?

Novo Nordisk A/V NYSE: NVO stock is testing the patience of buy-and-hold investors. Over the last five years, NVO stock is up more than 200%. However, in the last year, it’s down over 61% and more than 43% in 2025. Even in the volatile medical stocks sector, that kind of underperformance can’t be overlooked. Novo Nordisk A/S TodayNVONovo Nordisk A/S $48.86 +0.67 (+1.39%) 52-Week Range$ 46.90▼ $139.74Dividend Yield3.36%P/E Ratio14.46Price Target$ 93.67Add to WatchlistBut what’s making shareholders anxious right ...